{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:19:02Z","timestamp":1787797142005,"version":"build-2784847793"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T00:00:00Z","timestamp":1786147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100032160","name":"Task Force for Global Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.vaccine.2026.129004","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:51:32Z","timestamp":1786503092000},"page":"129004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Expanding adult immunization in low- and middle-income countries through pharmacist-provided vaccination"],"prefix":"10.1016","volume":"90","author":[{"given":"Lisa M.","family":"Koonin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shane D.","family":"Velez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Bresee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2026.129004_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines13040401","article-title":"Global status of adult immunization post COVID-19 pandemic","volume":"13","author":"Vilajeliu","year":"2025","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.129004_bb0010","author":"World Health Organization"},{"key":"10.1016\/j.vaccine.2026.129004_bb0015","author":"World Health Organization. Immunization"},{"key":"10.1016\/j.vaccine.2026.129004_bb0020","series-title":"Leveraging pharmacy to deliver life-course vaccination: an FIP global intelligence report","author":"International Pharmaceutical Federation (FIP)","year":"2024"},{"issue":"26","key":"10.1016\/j.vaccine.2026.129004_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126274","article-title":"Seasonal influenza vaccination: a global review of national policies in 194 WHO member states in 2022","volume":"42","author":"Goldin","year":"2024","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129004_bb0030","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/inthealth\/ihz120","article-title":"Taking stock of global immunisation coverage progress: the gains, the losses and the journey ahead","volume":"13","author":"Nnaji","year":"2021","journal-title":"Int Health"},{"key":"10.1016\/j.vaccine.2026.129004_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2025.100634","article-title":"Current evidence on improving influenza vaccine uptake in low- and middle-income countries: a scoping review of determinants and interventions","volume":"24","author":"Alam","year":"2025","journal-title":"Vaccine X"},{"issue":"48","key":"10.1016\/j.vaccine.2026.129004_bb0040","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1016\/j.vaccine.2015.10.066","article-title":"A systematic review of the social and economic burden of influenza in low- and middle-income countries","volume":"33","author":"de Francisco Shapovalova","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129004_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004333","article-title":"Costs and cost-effectiveness of influenza illness and vaccination in low- and middle-income countries: a systematic review from 2012 to 2022","volume":"21","author":"Gharpure","year":"2024","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2026.129004_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ypmed.2019.05.022","article-title":"A review of the cost-effectiveness of adult influenza vaccination and other preventive services","volume":"126","author":"Dabestani","year":"2019","journal-title":"Prev Med"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129004_bb0055","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2025.2602976","article-title":"A cost-benefit analysis of adult immunization programs across ten countries: modeling the socioeconomic value of immunization for older populations compared to no vaccination","volume":"21","author":"Chowdhury","year":"2025","journal-title":"Hum Vaccin Immunother"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129004_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004764","article-title":"Financial risk protection from vaccines in 52 Gavi-eligible low- and middle-income countries: a modeling study","volume":"22","author":"Jiao","year":"2025","journal-title":"PLoS Med"},{"key":"10.1016\/j.vaccine.2026.129004_bb0065","series-title":"The role of community pharmacists in vaccination: position paper. Brussels, Belgium: PGEU","author":"Pharmaceutical Group of the European Union (PGEU)","year":"2023"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129004_bb0070","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.japh.2022.06.008","article-title":"The impact of pharmacist involvement on immunization uptake and other outcomes: an updated systematic review and meta-analysis","volume":"62","author":"Le","year":"2022","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129004_bb0075","doi-asserted-by":"crossref","DOI":"10.1080\/20523211.2023.2285955","article-title":"Impact of pharmacist interventions on immunisation uptake: a systematic review and meta-analysis","volume":"17","author":"Rahim","year":"2023","journal-title":"J Pharm Policy Pract"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129004_bb0080","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/21645515.2020.1802973","article-title":"The impact of pharmacist-led educational intervention on pneumococcal vaccine awareness and acceptance among elderly in Jordan","volume":"17","author":"Abu-rish","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"36","key":"10.1016\/j.vaccine.2026.129004_bb0085","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1016\/j.vaccine.2022.07.054","article-title":"Adult vaccination uptake strategies in low- and middle-income countries: a systematic review","volume":"40","author":"Perroud","year":"2022","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2026.129004_bb0090","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1177\/87551225211052411","article-title":"Awareness, familiarity, and pharmacist trust: a structural equation model analysis","volume":"38","author":"Morrison","year":"2022","journal-title":"J Pharm Technol"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129004_bb0095","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.japh.2021.10.001","article-title":"Trust, influence, and community: why pharmacists and pharmacies are central for addressing vaccine hesitancy","volume":"62","author":"Shen","year":"2022","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.vaccine.2026.129004_bb0100","series-title":"Global strategy on human resources for health: workforce 2030","author":"World Health Organization","year":"2016"},{"issue":"7","key":"10.1016\/j.vaccine.2026.129004_bb0105","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.sapharm.2025.03.004","article-title":"Impact of pharmacist intervention on enhancing vaccination coverage: a systematic review and meta-analysis","volume":"21","author":"Elghanam","year":"2025","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.vaccine.2026.129004_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2026.128426","article-title":"Impact of pharmacy-based interventions on vaccination coverage among vulnerable and underserved populations: a systematic review and meta-analysis","volume":"78","author":"Borlini","year":"2026","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2026.129004_bb0115","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.sapharm.2025.06.110","article-title":"Impact of pharmacist-led interventions on COVID-19, herpes zoster, influenza, pneumococcal, and respiratory syncytial virus vaccines uptake in people aged 60 years and older: systematic review and meta-analysis","volume":"21","author":"Amare","year":"2025","journal-title":"Res Soc Adm Pharm"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129004_bb0120","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.sapharm.2020.03.016","article-title":"A systematic review of the role of pharmacists in vaccination services in low-and middle-income countries","volume":"17","author":"Yemeke","year":"2021","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.vaccine.2026.129004_bb0125","series-title":"2026 edelman trust barometer. Special report trust and health","author":"Edelman Trust Institute","year":"2026"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129004_bb0130","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1001\/dmp.2011.83","article-title":"CDC\u2019s 2009 H1N1 vaccine pharmacy initiative in the United States: implications for future public health and pharmacy collaborations for emergency response","volume":"5","author":"Koonin","year":"2011","journal-title":"Disaster Med Public Health Prep"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129004_bb0135","article-title":"Health worker influenza vaccination programs: a key to pandemic preparedness and effective COVID-19 vaccine deployment in low- and middle-income countries","volume":"14","author":"McCarron","year":"2026","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2026.129004_bb0140","doi-asserted-by":"crossref","first-page":"286","DOI":"10.15585\/mmwr.mm7313a2","article-title":"Federal retail pharmacy program contributions to bivalent mRNA COVID-19 vaccinations across sociodemographic characteristics \u2014 United States, September 1, 2022\u2013September 30, 2023","volume":"73","author":"El Kalach","year":"2024","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129004_bb0145","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/j.sapharm.2020.04.013","article-title":"Community pharmacists: on the frontline of health service against COVID-19 in LMICs","volume":"17","author":"Hedima","year":"2021","journal-title":"Res Soc Adm Pharm"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129004_bb0150","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s11096-021-01301-7","article-title":"Pharmacists\u2019 involvement in COVID-19 vaccination across Europe: a situational analysis of current practice and policy","volume":"43","author":"Paudyal","year":"2021","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.vaccine.2026.129004_bb0155","series-title":"Vaccine administration and prescribing by pharmacists: scope of services, training and impact [monograph]","author":"International Pharmaceutical Federation","year":"2024"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129004_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2024.102305","article-title":"Pharmacists\u2019 answer to the COVID-19 pandemic: contribution of the Federal retail pharmacy program to COVID-19 vaccination across sociodemographic characteristics\u2014United States","volume":"65","author":"El Kalach","year":"2025","journal-title":"J Am Pharm Assoc (2003)"},{"key":"10.1016\/j.vaccine.2026.129004_bb0165","author":"Congress"},{"issue":"46","key":"10.1016\/j.vaccine.2026.129004_bb0170","doi-asserted-by":"crossref","first-page":"5643","DOI":"10.1016\/j.vaccine.2016.09.020","article-title":"Integrating pharmacies into public health program planning for pandemic influenza vaccine response","volume":"34","author":"Fitzgerald","year":"2016","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129004_bb0175","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12960-021-00673-1","article-title":"Pharmacists as immunizers in Lebanon: a national survey of community pharmacists\u2019 willingness and readiness to administer adult immunization","volume":"19","author":"Youssef","year":"2021","journal-title":"Hum Resour Health"},{"issue":"4","key":"10.1016\/j.vaccine.2026.129004_bb0180","first-page":"98","article-title":"Pharmacists\u2019 willingness to offer vaccination services: a systematic review and meta-analysis","volume":"12","author":"Udoh","year":"2024","journal-title":"Pharmacy (Basel)"},{"issue":"2","key":"10.1016\/j.vaccine.2026.129004_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.943","article-title":"Community pharmacists workforce readiness to deliver vaccination services: a cross-sectional study from Jordan","volume":"10","author":"Alnahar","year":"2022","journal-title":"Pharmacol Res Perspect"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129004_bb0190","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-025-12655-3","article-title":"Community pharmacy workforce willingness, readiness, and infrastructural capacity to deliver vaccination services: a cross-sectional survey in Nigeria","volume":"25","author":"Oladigbolu","year":"2025","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.vaccine.2026.129004_bb0195","doi-asserted-by":"crossref","first-page":"292","DOI":"10.12688\/f1000research.131153.2","article-title":"Pharmacists\u2019 readiness and willingness to vaccinate the public in United Arab Emirates community pharmacies: a cross-sectional study","volume":"12","author":"Thomas","year":"2024","journal-title":"F1000Res"},{"key":"10.1016\/j.vaccine.2026.129004_bb0200","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.766146","article-title":"Pharmacist\u2019s perspectives on administering a COVID-19 vaccine in community pharmacies in four Balkan countries","volume":"9","author":"Turcu-Stiolica","year":"2021","journal-title":"Front Public Health"},{"issue":"5","key":"10.1016\/j.vaccine.2026.129004_bb0205","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.japh.2021.04.018","article-title":"Spinning the globe from west to east: a mixed-method study to examine the impact of pharmacists on immunization advocacy and delivery in Asia Pacific","volume":"61","author":"Lum","year":"2021","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129004_bb0210","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s40545-022-00478-0","article-title":"Readiness and willingness of Malaysian community pharmacists in providing vaccination services","volume":"15","author":"Ang","year":"2022","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.vaccine.2026.129004_bb0215","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s40545-023-00664-8","article-title":"Pharmacist-led vaccination services in the Middle East","volume":"16","author":"Aldajani","year":"2023","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.vaccine.2026.129004_bb0220","author":"Telishevska"},{"key":"10.1016\/j.vaccine.2026.129004_bb0225","article-title":"Seasonal influenza vaccination starts in pharmacies in Ukraine","author":"World Health Organization","year":"2024","journal-title":"WHO"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129004_bb0230","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1186\/s12913-024-11349-6","article-title":"Readiness of and barriers for community pharmacy professionals in providing and implementing vaccination services","volume":"24","author":"Ayenew","year":"2024","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129004_bb0235","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s41182-025-00698-5","article-title":"Quality and safety requirements for pharmacy-based vaccination in resource-limited countries","volume":"53","author":"G\/Michael Beyene","year":"2025","journal-title":"Trop Med Health"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129004_bb0240","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/hcs2.130","article-title":"Improving vaccination coverage through community pharmacy service delivery in Nigeria: the COVID-19 experience and implications for policy review","volume":"4","author":"Oseni","year":"2025","journal-title":"Health Care Sci"},{"key":"10.1016\/j.vaccine.2026.129004_bb0245","series-title":"Funding models, economic and societal impact of pharmacy-based vaccination: findings from FIP reports and literature","author":"International Pharmaceutical Federation (FIP)","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129004_bb0250","author":"American Pharmacists Association"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129004_bb0255","doi-asserted-by":"crossref","DOI":"10.1080\/29947677.2024.2443439","article-title":"Enhancing vaccine quality and accessibility: strategies for efficient storage and distribution in resource-constrained environment","volume":"1","author":"Scott","year":"2025","journal-title":"Outbreak Manag Response"},{"key":"10.1016\/j.vaccine.2026.129004_bb0260","series-title":"Joint FIP\/WHO guidelines on good pharmacy practice: standards for quality of pharmacy services","author":"International Pharmaceutical Federation (FIP)","year":"2011"},{"issue":"1","key":"10.1016\/j.vaccine.2026.129004_bb0265","doi-asserted-by":"crossref","DOI":"10.1080\/20523211.2025.2475082","article-title":"The paradox of community pharmacy practice in low- and middle-income countries (LMICs)","volume":"18","author":"Kheir","year":"2025","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/j.vaccine.2026.129004_bb0270","series-title":"Creating community-clinical linkages between community pharmacists and physicians: a pharmacy guide","author":"US Centers for Disease Control and Prevention (CDC) \/ American Pharmacists Association \/ American Medical Association","year":"2017"},{"key":"10.1016\/j.vaccine.2026.129004_bb0275","article-title":"International pharmaceutical federation (FIP). Pharmacy-based vaccination assessment tool","year":"2026","journal-title":"Hague: Int Pharmaceutical Federation"},{"key":"10.1016\/j.vaccine.2026.129004_bb0280","series-title":"FIP knowledge and skills reference guide for professional development in vaccination services","author":"International pPharmaceutical fFederation (FIP)","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129004_bb0285","series-title":"Global situation report on pharmacy 2025: workforce, practice and policy","author":"International Pharmaceutical Federation (FIP)","year":"2025"},{"key":"10.1016\/j.vaccine.2026.129004_bb0290","series-title":"Review of pharmacist vaccination reporting to the Australian immunisation register (AIR)","author":"Hull","year":"2020"},{"key":"10.1016\/j.vaccine.2026.129004_bb0295","author":"US Centers for Disease Control and Prevention (CDC)"},{"issue":"6","key":"10.1016\/j.vaccine.2026.129004_bb0300","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/1715163519877906","article-title":"Making it happen: strategies to incorporate vaccinations into community pharmacy practice","volume":"152","author":"Houle","year":"2019","journal-title":"Can Pharm J (Ott)"},{"key":"10.1016\/j.vaccine.2026.129004_bb0305","author":"International Pharmaceutical Federation (FIP)"},{"issue":"35","key":"10.1016\/j.vaccine.2026.129004_bb0310","doi-asserted-by":"crossref","first-page":"5089","DOI":"10.1016\/j.vaccine.2019.06.049","article-title":"The partnership for influenza vaccine introduction (PIVI): supporting influenza vaccine program development in low and middle-income countries through public-private partnerships","volume":"37","author":"Bresee","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2026.129004_bb0315","author":"American Pharmacists Association"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26008133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T02:11:46Z","timestamp":1787796706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26008133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":63,"alternative-id":["S0264410X26008133"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129004","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding adult immunization in low- and middle-income countries through pharmacist-provided vaccination","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.129004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"129004"}}